Key Takeaways
- President Trump held White House talks with Ukrainian President Zelensky and European leaders on the Ukraine war.
- A New York appeals court delayed a decision for nearly a year on President Trump's civil fraud case.
- European companies are increasingly moving stock listings to the U.S. due to struggling domestic IPO markets.
- President Trump aims to eliminate mail-in voting by 2026, a move criticized by Democrats and legal experts.
- The Trump administration is discussing acquiring a 10% stake in Intel to bolster U.S. semiconductor manufacturing.
Deep Dive
- President Trump met Ukrainian President Volodymyr Zelensky and European officials at the White House to discuss the Ukraine war, following a summit with Russian President Vladimir Putin.
- WSJ national security reporter Lara Seligman noted Trump signaled openness to U.S. security guarantees, but details on a peacekeeping framework involving British and French forces were limited.
- Trump appeared to back away from a ceasefire as a crucial step, despite the meeting being significantly warmer and more optimistic than previous interactions.
- Fundamental progress on peace, including ceasefire or territory swaps, has not been achieved.
- A New York appeals court has delayed a decision for nearly a year on President Trump's civil fraud case, an unusual wait for the typically swift court.
- The case stems from a 2022 lawsuit by New York Attorney General Letitia James, alleging fraudulent inflation of real estate values.
- A previous judgment against Trump amounted to over $350 million plus interest and business sanctions.
- WSJ reporter Corinne Ramey suggested the delay is likely due to the five-justice panel writing three separate opinions, indicating a split.
- The outcome could impose over half a billion dollars in penalties and restrictions on Trump and his sons.
- Initial public offerings in the UK have reached a three-decade low with only six companies going public this year.
- Continental European IPO values have nearly halved, while fundraising in the U.S. jumped 38% to $40 billion.
- Companies including AstraZeneca, Shell, and Total Energies are considering moving their listings to New York, leading to shrinking European stock exchanges.
- The shift of fast-growing companies to the U.S. poses a significant problem for Europe's economy by reducing growth potential.
- European officials are discussing solutions such as deregulation and replicating the U.S. 401k system to encourage domestic stock investment.